Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 29, 2018
Event: Notice of transfer of listing to The Nasdaq Capital Market effective October 30, 2018.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document solely addresses a corporate governance event regarding stock exchange listing status.
Material Changes
- Listing Transfer: The company's listing was transferred to The Nasdaq Capital Market.
- Compliance Status: Following the transfer, vTv Therapeutics Inc. fully complies with The Nasdaq Capital Market's continued listing standards.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a procedural notice confirming the listing transfer and compliance with new listing standards.
Investor Verification Checklist
- Verify the effective date of the listing transfer (October 30, 2018).
- Confirm the company's compliance status with The Nasdaq Capital Market continued listing standards.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the transfer.